ALAB Stock Analysis: Astera Labs | NASDAQ

Semiconductors | NASDAQ, USA | Market Cap: 59.368m USD | 12M Return: 62.4% | US04626A1034 | Charts, Fundamentals & Technical Analysis

Retimers, Cable Modules, Memory Controllers, Fabric Switches
Total Rating 52
Safety 38
Buy Signal 0.19
Semiconductors
Industry Rotation: +3.4
Market Cap: 59.4B
Avg Turnover: 1.43B
Risk 3d forecast
Volatility94.9%
VaR 5th Pctl15.5%
VaR vs Median-0.64%
Reward TTM
Sharpe Ratio0.91
Rel. Str. IBD93.3
Rel. Str. Peer Group76.4
Character TTM
Beta3.873
Beta Downside2.536
Hurst Exponent0.429
Drawdowns 3y
Max DD63.69%
CAGR/Max DD1.43
CAGR/Mean DD3.11
EPS (Earnings per Share) EPS (Earnings per Share) of ALAB over the last years for every Quarter: "2022-03": null, "2022-06": null, "2022-09": null, "2022-12": null, "2023-03": null, "2023-06": null, "2023-09": null, "2023-12": 0.12, "2024-03": 0.27, "2024-06": 0.13, "2024-09": 0.23, "2024-12": 0.37, "2025-03": 0.33, "2025-06": 0.44, "2025-09": 0.49, "2025-12": 0.58, "2026-03": 0.61, "2026-06": 0.49,
Last SUE: 2.10
Qual. Beats: 5
Revenue Revenue of ALAB over the last years for every Quarter: 2022-03: 15.018, 2022-06: 21.396, 2022-09: 23.103, 2022-12: 20.355, 2023-03: 17.664, 2023-06: 10.688, 2023-09: 36.928, 2023-12: 50.514, 2024-03: 65.258, 2024-06: 76.85, 2024-09: 113.086, 2024-12: 141.096, 2025-03: 159.442, 2025-06: 191.925, 2025-09: 230.575, 2025-12: 270.583, 2026-03: 308.361, 2026-06: 392.4,
Rev. CAGR: 158.98%
Rev. Trend: 99.0%
Last SUE: 4.00
Qual. Beats: 6

Warnings

P/E Ratio 168.6
Beneish M-Score Likely Earnings Manipulation
Choppy
Below Avwap Earnings

Tailwinds

Rs Leader
Confidence

Seasonality 2.5 years of data

Jan -11.7% -
Feb -23.1% -
Mar -13.3% 33
Apr +40.6% 32
May +51.6% 38
Jun +12.3% 0
Jul -8.3% 0
Aug +3.3% 26
Sep -9.3% -
Oct -12.1% -
Nov -18.4% -
Dec +2.9% -

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: ALAB Astera Labs

Astera Labs, Inc. (NASDAQ: ALAB) is a U.S.-based fabless semiconductor company that designs, manufactures (via external foundries), and sells high-speed connectivity solutions purpose-built for cloud and AI infrastructure. Its core offering is the Astera Intelligence Connectivity Platform, a semiconductor-based, mixed-signal portfolio that integrates microcontrollers, sensors, and the COSMOS software suite for fleet-level management and optimization. The company sells primarily to hyperscalers and system original equipment manufacturers, with revenue concentrated in Taiwan and the United States.

The product portfolio spans PCIe/CXL smart DSP retimers and cable modules, ethernet smart cable modules for AI and cloud workloads, CXL memory connectivity controllers, and smart fabric switches. These products sit at the critical data-movement layer inside AI server racks, where high-bandwidth, low-latency interconnects between GPUs, accelerators, memory, and networking gear are essential. The connectivity semiconductor segment has been a structural beneficiary of hyperscaler capital expenditure on AI data centers, as larger GPU clusters require more retimers, optical interconnects, and switching fabric per rack.

Founded in 2017 and headquartered in San Jose, California, Astera Labs went public on March 20, 2024, and is classified within the Information Technology sector and Semiconductors sub-industry under the GICS taxonomy. As a fabless designer, the company outsources wafer fabrication and focuses internal resources on chip design, validation, and software-a model common among U.S. semiconductor firms that allows for higher gross margins but creates reliance on third-party foundries.

Headlines to Watch Out For
  • AI server buildouts drive retimer and fabric switch demand
  • Hyperscaler customer concentration exposes revenue to capex volatility
  • Broadcom and Marvell competition pressures AI connectivity market share
Piotroski VR-10 (Strict) 3.0
Net Income: 369.5m TTM > 0 and > 6% of Revenue
FCF/TA: 0.14 > 0.02 and ΔFCF/TA -2.22 > 1.0
NWC/Revenue: 123.8% < 20% (prev 177.4%; Δ -53.65% < -1%)
CFO/TA 0.17 > 3% & CFO 335.7m > Net Income 369.5m
Net Debt (-1.21b) to EBITDA (334.0m): -3.63 < 3
Current Ratio: 10.05 > 1.5 & < 3
Outstanding Shares: last quarter (182.3m) vs 12m ago 2.33% < -2%
Gross Margin: 75.13% > 18% (prev 75.52%; Δ -0.39% > 0.5%)
Asset Turnover: 75.05% > 50% (prev 47.63%; Δ 27.42% > 0%)
Interest Coverage Ratio: error (cannot be calculated; needs correct EBIT TTM and Interest Expense TTM)
Altman Z'' 10.00
A: 0.77 (Total Current Assets 1.65b - Total Current Liabilities 164.3m) / Total Assets 1.93b
B: 0.13 (Retained Earnings 243.7m / Total Assets 1.93b)
C: 0.20 (EBIT TTM 322.0m / Avg Total Assets 1.60b)
D: 8.39 (Book Value of Equity 1.73b / Total Liabilities 205.8m)
Altman-Z'' = 15.62 = AAA
Beneish M 0.93
DSRI: 3.0 (Receivables 192.5m/24.3m, Revenue 1.20b/605.5m)
GMI: 1.01 (GM 75.52% / 75.13%)
AQI: 3.69 (AQ_t 0.08 / AQ_t-1 0.02)
SGI: 1.98 (Revenue 1.20b / 605.5m)
TATA: 0.02 (NI 369.5m - CFO 335.7m) / TA 1.93b)
Beneish M = 0.93 (Cap -4..+1) = D
What is the price of ALAB shares?

As of October 13, 2026, the stock is trading at USD 324.11 with a total of 3,731,434 shares traded. Over the past week, the price has changed by -10.55%, over one month by +26.09%, over three months by -10.48% and over the past year by +62.44%.

Current recommended Stop Loss: 285.00 (which is 12.1% or 1.6 ATR below the current price).

Is ALAB a buy, sell or hold?

Astera Labs has received a consensus analysts rating of 4.19. Therefore, it is recommended to buy ALAB.

  • StrongBuy: 12
  • Buy: 7
  • Hold: 7
  • Sell: 0
  • StrongSell: 0

What are the forecasts/targets for the ALAB price?
Analysts Target Price 391.8 20.9%
Astera Labs (ALAB) - Fundamental Data Overview as of 12 October 2026
Market Cap USD = 59.4b (59.4b USD * 1.0 USD.USD)
P/E Trailing = 168.5764
P/E Forward = 55.5556
P/S = 49.3946
P/B = 36.2371
Revenue TTM = 1.20b USD
EBIT TTM = 322.0m USD
EBITDA TTM = 334.0m USD
 Long Term Debt = unknown (none)
 Short Term Debt = 5.70m USD (from shortTermDebt, two quarters ago)
Debt = 39.3m USD (from shortLongTermDebtTotal, last fiscal year) + Leases 4.15m
Net Debt = -1.21b USD (calculated: Debt 39.3m - CCE 1.25b)
Enterprise Value = 58.2b USD (59.4b + Debt 39.3m - CCE 1.25b)
 Interest Coverage Ratio = unknown (Ebit TTM 322.0m / Interest Expense TTM 0.0)
 EV/FCF = 210.2x (Enterprise Value 58.2b / FCF TTM 276.7m)
FCF Yield = 0.48% (FCF TTM 276.7m / Enterprise Value 58.2b)
FCF Margin = 23.02% (FCF TTM 276.7m / Revenue TTM 1.20b)
Net Margin = 30.74% (Net Income TTM 369.5m / Revenue TTM 1.20b)
Gross Margin = 75.13% ((Revenue TTM 1.20b - Cost of Revenue TTM 298.9m) / Revenue TTM)
Gross Margin QoQ = 73.28% (prev 76.26%)
Tobins Q-Ratio = 30.11 (Enterprise Value 58.2b / Total Assets 1.93b)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 39.3m)
Taxrate = 21.0% (US federal default 21%)
NOPAT = 254.4m (EBIT 322.0m * (1 - 21.00%))
Current Ratio = 10.05 (Total Current Assets 1.65b / Total Current Liabilities 164.3m)
Debt / Equity = 0.02 (Debt 39.3m / totalStockholderEquity, last quarter 1.73b)
Debt / EBITDA = -3.63 (Net Debt -1.21b / EBITDA 334.0m)
Debt / FCF = -4.39 (Net Debt -1.21b / FCF TTM 276.7m)
Total Stockholder Equity = 1.46b (last 4 quarters mean from totalStockholderEquity)
RoA = 23.07% (Net Income 369.5m / Total Assets 1.93b)
RoE = 25.24% (Net Income TTM 369.5m / Total Stockholder Equity 1.46b)
RoCE = 18.22% (EBIT 322.0m / Capital Employed (Total Assets 1.93b - Current Liab 164.3m))
RoIC = 14.90% (NOPAT 254.4m / Invested Capital 1.71b)
WACC = 19.60% (E(59.4b)/V(59.4b) * Re(19.61%) + D(39.3m)/V(59.4b) * Rd(0.0%) * (1-Tc(0.21)))
Discount Rate = 19.61% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 87.01 | Cagr: 7.82%
[DCF] Terminal Value 49.69% ; FCFF base≈250.2m ; Y1≈286.8m ; Y5≈422.0m
[DCF] Fair Price = 18.99 (EV 2.08b - Net Debt -1.21b = Equity 3.29b / Shares 173.5m; r=19.60% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 2.10 | # QB: 5
Revenue Correlation: 98.98 | Revenue CAGR: 159.0% | SUE: 4.0 | # QB: 6
EPS current Quarter (2026-09-30): EPS=1.19 | Chg30d=+0.00% | Revisions=+86% | Analysts=20
EPS current Year (2026-12-31): EPS=4.03 | Chg30d=+0.00% | Revisions=+88% | GrowthEPS=+119.1% | GrowthRev=+123.9%
EPS next Year (2027-12-31): EPS=6.39 | Chg30d=+0.00% | Revisions=+87% | GrowthEPS=+58.6% | GrowthRev=+55.8%
[Analyst] Revisions Ratio: +95% (up=60, down=0)